Canalization, also known as developmental robustness, describes an organism's ability to produce the same phenotype despite genotypic variations and environmental influences 1,2 . In Drosophila, Hsp90, the trithorax-group proteins and transposon silencing have been previously implicated in canalization 3, 4 . Despite this, the molecular mechanism underlying canalization remains elusive. Here using a Drosophila eye-outgrowth assay sensitized by the dominant Kr irregular facets-1 (Kr If-1 ) allele 3 , we show that the Piwiinteracting RNA (piRNA) pathway, but not the short interfering RNA or micro RNA pathway, is involved in canalization. Furthermore, we isolated a protein complex composed of Hsp90, Piwi and Hop, the Hsp70/Hsp90 organizing protein homolog, and we demonstrated the function of this complex in canalization. Our data indicate that Hsp90 and Hop regulate the piRNA pathway through Piwi to mediate canalization. Moreover, they point to epigenetic silencing of the expression of existing genetic variants and the suppression of transposoninduced new genetic variation as two major mechanisms underlying piRNA pathway-mediated canalization.
In both plants and animals, Hsp90 buffers against morphological changes induced either by genetic or non-genetic mechanisms, thereby promoting the robustness of the developmental programs that have been subjected to natural selection [5] [6] [7] [8] . However, under certain conditions, such as environmental stress, Hsp90 becomes overwhelmed, loosens its grip on canalization and fails to repress the expression of genotype variants that have accumulated during evolution. The expressed phenotypes quickly become independent of Hsp90 deficiency, can be inherited in later generations and could be subject to natural selection 3, 5 . In addition to Hsp90, maternally inherited epigenetic machineries also prevent expression of genotypic variants 3 , indicating that faithful transmission of epigenetic marks across generations is also critical for canalization. Hence, examining the regulation of epigenetic inheritance should provide important insights into the molecular mechanisms underlying canalization. Piwi, a piRNA-binding protein, is implicated in epigenetic regulation as both a maternal and a zygotic factor [9] [10] [11] [12] [13] [14] . Hence, we reasoned that Piwi might mediate canalization through its epigenetic function.
To test our hypothesis, we used a dominant gain-of-function allele, Kr , that ectopically expresses Krüppel, a zinc-finger transcription factor, in the ventral region of the developing eye imaginal disc 15 . This ectopic expression misregulates homeotic genes in the eye disc and generates eye outgrowths, which, however, are normally repressed and present only in less than 0.1% of Kr If-1 progeny 3, 15, 16 . The loss-offunction mutations of Hsp83 and the trx group of genes enhance the expression of this phenotype, implicating these factors in canalization 3 . We used this sensitized assay to examine if a reduction in maternal dose of Piwi also enhances the outgrowths. The genetic cross was setup as shown in Figure 1a . We observed that strong piwi alleles, piwi 1 and piwi 2 , are dominant enhancers of the eye outgrowth phenotype induced by Krüppel ectopic expression (Fig. 1b) . When piwi 1/+ or piwi 2/+ female flies were crossed with Kr If-1/+ males, we observed the outgrowth phenotype in approximately 7% of the progeny (n = 146). The reciprocal cross (Kr If-1/+ females × piwi 1/+ or piwi 2/+ males), however, produced no offspring with the outgrowth (n = 122; data not shown), indicating that maternal Piwi mediates canalization in a dose-sensitive fashion.
If canalization is solely mediated by maternal Piwi, it should be independent of the genotype of the progeny. Instead, we found that the expression of the outgrowth phenotype also depends on the presence of piwi mutation in the progeny, as only Kr If-1 /piwi 2 progeny, but not their Kr If-1/+ siblings, express the phenotype (Fig. 1b) . These data indicate that zygotic Piwi also plays a role in canalization and that both piwi 1 and piwi 2 produce the same phenotype as the loss-offunction alleles of Hsp83 and the trx group of genes 3 .
To further link the outgrowth phenotype to the ectopic expression of genes underlying the outgrowth, we examined the expression of wg (wingless) in eye imaginal discs of the progeny of piwi +/+ and piwi 1 (Supplementary Fig. 1a ). This indicates that the Piwi-piRNA pathway can affect non-transposon gene expression in a dose-sensitive manner to achieve canalization.
We next examined whether canalization is specific to piwi. Reduction in maternal dose of Aubergine, another Piwi subfamily protein involved in the piRNA pathway, resulted in ~16% of progeny with the eye outgrowth phenotype (Supplementary Fig. 1b) . However, reduction in maternal doses of Dicer-1 or Dicer-2, key proteins in the miRNA and siRNA pathways, respectively, did not result in any Fig. 1c ). These findings indicate that canalization is mediated by the piRNA pathway but not the miRNA or siRNA pathway.
It is argued that canalization is a general feature of complex gene networks and that perturbation in any node of these networks can lead to compromised canalization 17 . Hence, we examined whether Piwi and Hsp90 function in the same pathway or in parallel pathways that happen to produce similar phenotypes. We tested if overexpression of maternal Piwi suppresses the eye outgrowth phenotypes of Hsp83 induced by geldanamycin, a chemical that specifically inhibits Hsp90 and induces eye outgrowths in Kr If-1 flies 3 . To overexpress maternal Piwi, we used a transgenic myc-piwi line (G38), wherein a fully functional myc-piwi gene was inserted into the second chromosome that contains endogenous piwi 13, 18 , thereby increasing the piwi copy number to four. We generated Kr If-1 /myc-piwi virgin females (which contain three copies of piwi) and crossed them to Kr If (Fig. 1d) .
To explore the molecular mechanism underlying the Piwi-mediated canalization, we fractionated cytoplasmic extracts of 0-12 h embryos using column chromatography ( Fig. 2 and Supplementary Fig. 2 ). After the final column, Piwi migrated with an apparent molecular weight of ~150 kDa ( Fig. 2a and Fig. 2c, upper panel) . We resolved the peak fraction for Piwi (#27) using gel electrophoresis. We visualized co-migrating peptides using silver staining (Fig. 2b) , excised from the gel, and identified by mass spectrometry. In addition to Piwi that migrates at ~90 kDa, we identified another abundant protein migrating at ~60 kDa as Hsp70/Hsp90 Organizing Protein Homolog (Hop, CG2720; Fig. 2b l e t t e r s chromatography (Fig. 2c) . This interaction was further confirmed by co-immunoprecipitation of Piwi with Hop from 0-12 h embryonic extracts (Fig. 2d) . Hop contains three tetratricopeptide repeats (TPR1a, TPR2a and TPR2b) and a small DP repeat motif called DP2 (refs. 19,20) . The TPR1 domain of Hop binds to Hsp70, and the TPR2a domain binds to Hsp90 (refs. 21, 22) . Furthermore, in support of our genetic experiments implicating Piwi as a client of the highly selective chaperone Hsp90 (Fig. 1c) , we found that Piwi and Hop together co-immunoprecipitate with Hsp90 ( Fig. 2d,e) . These results indicate that Piwi, Hop and Hsp90 likely exist in the same complex.
To seek for a second line of evidence for the Piwi-Hop-Hsp90 complex, we tried immunoprecipitating Piwi, but we noted that an antibody against first 200 amino acids of Piwi failed to immunoprecipitate both Hop and Hsp90 (Fig. 2d , see Piwi IP lane). This may be due to either of the two possibilities: i) Hop and Hsp90 hold Piwi in a conformation where its N terminus is not accessible or ii) the Piwi antibody recognition site is the same as the Hop or Hsp90 binding site. This possibility is supported by the fact that N-terminal antibody does not recognize Piwi in situ when it is presumably associated with proteins such as Heterochromatin Protein 1a that binds to residues 28-32 of Piwi 12 . Hence, to provide an independent line of evidence for the PiwiHop-Hsp90 complex, we co-expressed His-SUMO-Piwi, Myc-Hop and HA-Hsp90 in the rabbit reticulocyte lysate system and conducted serial immunoprecipitation on the lysate (Fig. 2f) . After the second immunoprecipitation, we found that Piwi exists in the same pool as both Hop and Hsp90. This verified that Piwi, Hop and Hsp90 exist in the same complex. The above findings, together, led us to hypothesize that Hsp90, Hop and Piwi function in the same complex, in which Hop mediates interaction between Piwi and Hsp90.
To test this hypothesis, we reasoned that a reduction in maternal dose of Hop would also compromise canalization. When we crossed Hop k00616/+ virgin females with Kr If-1 /Kr If-1 males, we observed 5-6% of the male progeny with the eye outgrowth phenotype (Fig. 3) . This observation confirmed our hypothesis and demonstrated that Hop is also a dominant enhancer of the Kr If-1 phenotype. The male-only outgrowth might be because some of the mutations required for the outgrowth are X-linked recessive and need hemizygosity or homozygosity to be expressed. As in the case of Piwi and Hsp90, the reciprocal cross with the Hop k00616 inherited from the father did not produce any outgrowth phenotype (data not shown). Hence, maternal Hop plays a critical role in canalization, likely by mediating interaction between Hsp90 and Piwi.
We then further examined if the outgrowth phenotype generated in piwi 1 and Hop k00616 mutants can become independent of the piwi and Hop mutations and transmitted to the next generation (Fig. 4a) . We crossed males with eye outgrowths with virgin Canton-S flies to separate piwi 1 (Fig. 4b) . Consistent with the link between wg expression and eye outgrowth phenotype, we observed higher wg expression in the heads of F8 flies with the outgrowth phenotype (Fig. 4c) . This indicates that phenotypic variants and their corresponding gene expression patterns, once induced by piwi and Hop mutations, can be 'fixed' in a population and then stably inherited in subsequent generations under selection. As Hsp90 and Piwi are in the same complex, yet overexpression of Piwi can rescue the deficiency of Hsp90 in canalization, Hsp90 and Piwi must function in the same pathway, with Piwi acting downstream of Hsp90. We therefore further examined how Hsp90 may regulate Piwi function. We first examined whether Hsp90 regulates Piwi expression and/or stability by comparing the Piwi levels in wildtype flies with and without geldanamycin treatment (Fig. 5a) , and we further confirmed these results in Hsp83 08445 /Hsp83 08445 mutants (Fig. 5b) . As expected, the known Hsp90 client proteins Akt and B-Raf became unstable after geldanamycin treatment (Fig. 5a) . However, the Piwi protein levels did not change either with geldanamycin treatment or in Hsp83 08445 /Hsp83 08445 mutants (Fig. 5a,b) . This indicates that Hsp90 does not regulate the expression and/or stability of Piwi.
However, Hsp90 regulates the post-translational modification of Piwi. In wildtype conditions, two-dimensional gel electrophoresis revealed three isoforms of Piwi with isoelectric point (pI) ~ 10 ( Fig. 5c,  first panel, isoforms 2, 3, and 4) . These isoforms are likely due to different levels of phosphorylation because they have very similar molecular weights but different pI values. Upon inhibition of Hsp90 by geldanamycin, we noticed the appearance of a new isoform that is less negatively charged (Fig. 5c, second (Fig. 5c, third panel, black arrow) and an appearance of a new isoform that migrated between isoforms 2 and 3 but was closer to isoform 2 (Fig. 5c, fourth panel, black arrow head) .
To test whether this post-translational modification is indeed phosphorylation, we treated Hsp83 08445 /TM3 ovary lysate with calf intestinal phosphatase (CIP) and then subjected the lysate to twodimensional gel analysis. After CIP treatment, we noticed a complete absence of isoforms 3 and 4 (Fig. 5c, bottom panel, circled area) and a reduced intensity of isoforms 1 and 2. This confirms that the four isoforms are indeed phosphorylated forms of Piwi.
To further verify the phosphorylation of Piwi and determine the type of phosphorylation, we performed immunoprecipitation using phospho-serine, phospho-threonine and phospho-tyrosine antibodies, followed by protein blotting analysis of the immunoprecipitates with Piwi antibody. Piwi was immunoprecipitated by both phophoserine and phospho-tyrosine antibodies but not by the phosphothreonine antibody (Fig. 5d) . Consistent with this, phospho-serine and phospho-tyrosine antibodies failed to immunoprecipitate Piwi when the lysate was treated with CIP before immunoprecipitation (Fig. 5e) . These results indicate that Piwi is phosphorylated on serine and tyrosine residues.
To investigate whether the phosphorylation of serine and tyrosine residues in Piwi is dependent on Hsp90, we conducted the phosphoPiwi immunoprecipitation in wildtype and Hsp83 mutant ovarian lysates. Both phopho-serine and phospho-tyrosine antibodies immunoprecipitated Piwi from wildtype but not from Hsp83 mutant ovarian lysates (Fig. 5f) . These results indicate that Hsp90 is required for the phosphorylation of Piwi. A salient feature of Hsp90-mediated chaperoning, unlike that of Hsp70, is that it predominantly binds to metastable states of proteins instead of hydrophobic stretches 7 I n p u t -I P P -S e r I P P -T y r I P P -S e r I P P -T y r I P P -S e r I P P -T y r I P I n p u t -I P P -S e r I P P -T h r I P P -T y r I P Darker exposure 
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Recently, results from a previous study suggested that Hsp90 prevents phenotypic variation by suppressing transposon-induced mutagenesis through piRNAs 4 . Having demonstrated that Hsp90 forms a complex with Piwi and regulates its phosphorylation, we set out to test whether this hypothesis is true. It has been observed that deficiency in Hsp90 activity reduces piRNA expression, activates transposition, compromises multiple aspects of DNA damage repair and increases CAG-repeat instability, which ultimately produce genotype variations 4, [23] [24] [25] [26] . Consistent with this previous study 4 , we observed an increase in the RNA levels of transposons upon geldanymycin treatment (Supplementary Fig. 3) , even though this treatment did not decrease the mRNA and protein levels of Piwi (Supplementary Fig. 3b,c) . Furthermore, this increase can be largely repressed by increasing the piwi copy number to four (Supplementary Fig. 3a) . These data further support that a mechanism through which Hsp90 achieves canalization is the suppression of new mutations through transposition and deficiency in DNA repair.
However, our experiments suggest that Hsp90, Hop and Piwi mediate canalization also through a non-genetic mechanism. First, we found that the eye outgrowth phenotype was observed only when either piwi or Hop mutations were in the mother. This is in contrast to the recent report that geldanaymycin treatment can de-repress transposons mainly in the male germline 4 . If eye outgrowths resulted from a genetic lesion, it should be independent of the parental source of contribution. Second, we have observed no increase in transposon RNA levels in the female germ line of piwi 1/+ (Supplementary Fig. 4a ), meaning one copy of piwi is sufficient to silence transposons, which is consistent with a previous report that piwi is haplo-sufficient to prevent new transpositions in the progeny 27 . However, piwi is haploinsufficient to suppress eye outgrowths (Fig. 1) , as well as position effect variegation (Supplementary Fig. 4b) . Thus, the eye outgrowth phenotype observed in Kr If-1 /piwi 1 is unlikely due to new genetic mutations caused by transposons. Third, in Kr If-1 /Kr If-1 files eight generations (F8) after piwi and Hop mutations were outcrossed, new mutations from the F1 flies, if any, should have been fixed. However, among these F8 flies, those with the outgrowth phenotype had approximately 50-60% more Kr mRNA and at least twice as much wg mRNA in their heads as compared to their siblings without the phenotype (Fig. 4c) . These statistically significant differences in Kr and wg expression among the same population of flies are more difficult to be explained by a stable genetic change by transposons. Last but not least, Piwi has been broadly implicated in epigenetic regulation, from long range physical interaction among Polycomb group response elements to Heterochromatin Protein 1-mediated epigenetic silencing [9] [10] [11] [12] [13] [14] . Hence, we conclude that eye outgrowth phenotypes we observed in this study are due to defects in epigenetic silencing of normally non-expressed genotypes, so-called cryptic genotypes, by maternal Piwi rather than new transposon insertions.
The mechanism of canalization has been a subject of great debate. A previous study's findings indicate that Hsp90 acts as a capacitor for phenotypic variation 5 ; however, a complex gene network model generated by another group of researchers predicts that a mutation in any one gene can result in expression of cryptic genotypes 17 . Yet another report argues that expression of cryptic genotypes is not caused by canalization and no particular mechanism is needed to prevent expression of the cryptic phenotypes 28 . Our finding of piwi and Hop mutations as enhancers for expression of cryptic genotypes validates the existence of a piRNA-pathway-dependent mechanism for preventing phenotypic variation. Piwi is a piRNA-binding protein that is required for silencing of transposons 29 and epigenetic regulation 13, 30 . Hence, post-translational regulation of Piwi by Hsp90 and Hop may allow Piwi to both suppress the generation of new genotypes and epigenetically silence the expression of existing genetic variants (Fig. 6) . Both mechanisms can be 'fixed' and inherited in subsequent generations. Our study also shows that Piwi acts at two distinct phases of fly development in mediating phenotypic capacitance. First, maternal Piwi plays a direct role in canalization and/or suppresses transposon-induced mutagenesis during embryogenesis. This allows the inheritance of correct epigenetic and genetic codes from parental cells to daughter cells, thereby ensuring the robustness of the developmental programs. Subsequently, zygotic Piwi is required for maintaining the inherited developmental programs during subsequent stages of development. This Piwi function likely represents the piRNA pathway, as Aubergine, a Piwi homolog also involved in the piRNA pathway, has a similar function. Furthermore, canalization appears to involve only the piRNA pathway but not the miRNA or siRNA pathway, as Dicer-1 and Dicer-2 deficiency does not lead to increased eye outgrowth.
Then, what could be the roles for Hsp90 and Hop in Piwi-mediated canalization? As an essential component in canalization, Hsp90 likely ensures proper function of its clients involved in canalization, such as Piwi, by mediating their proper post-translational modification, such as phosphorylation, that is required for their molecular activities. A salient feature of Hsp90-mediated chaperoning, unlike Hsp70, is that Hsp90 predominantly binds to metastable states of proteins instead of hydrophobic stretches 7 . The Hsp90-bound metastable state of Piwi may be a necessary step for its phosphorylation at proper sites, which may then be required to form active complexes with piRNAs and/or epigenetic factors to promote epigenetic and transposon silencing, leading to canalization.
MetHODs
Methods and any associated references are available in the online version of the paper at http://www.nature.com/naturegenetics/.
ONLINe MetHODs
Fly stocks and maintenance. All fly stocks were maintained at 25 °C. piwi 1 , piwi 2 alleles and myc-piwi transgenes were generated by P-element insertions and are described elsewhere 18, 31 L811fsX /Cyo strains were gifts from R. Carthew and are described elsewhere 32 .
Pharmacological inhibition of Hsp83. Geldanamycin (Sigma) was first dissolved in 50% ethyl alcohol to make a ×1,000 stock (3.56 mM). To make Drosophila medium containing geldanamycin, a scoop of Formula 4-24 (Carolina biological supply) was mixed with 15 ml of water containing 3.56 µM geldanamycin. After mixing food and water in a vial, it was left to solidify for 1 minute before adding flies. Alternatively, geldanamycin was dissolved in DMSO to make a stock of 10 mM from where fly medium containing geldanamycin was prepared as described above. For inhibiting Hsp90 in vivo, we allowed female flies to feed on geldanamycin containing medium for either 2 days (Supplementary Fig. 4a ) or 4 days (Fig. 5a ) before dissecting ovaries and lysate preparation.
Embryo collection and extract preparation. w 1118 flies were grown at 25 °C and 70-80% relative humidity in population cages and embryos were collected on grape juice agar plates at 12-h intervals. Embryos were carefully transferred using a soft paint brush into mini embryo collection cages (Genesee Scientific) and washed well with tap water to remove traces of yeast. The embryos were then dechorionated by immersing in 50% bleach (Chlorox) for 2 min and rinsed with embryo wash buffer (0.7% NaCl (wt/vol), 0.02% Triton X-100 (vol/vol) and tap water. They were then dried on a paper towel and stored at −80 °C until further use.
All steps in extract preparation were performed at 4 °C. Ten grams of frozen embryos were thawed on ice and carefully resuspended in 3 ml per gram of embryos of H (0.3) buffer (25 mM HEPES-NaOH, pH 7.8, 300 mM NaCl, 0.5 mM EGTA, 0.1 mM EDTA, 2 mM MgCl 2 , 0.02% NP-40 and 20% glycerol), where the number in the parenthesis represents the final NaCl concentration in the buffer (0.3 M). Just before use, the buffer was supplemented with one tablet of Complete Mini-EDTA free protease inhibitor cocktail (Roche) per 10 ml of the buffer, 1 mM phenylmethanesulfonyl fluoride (Fluka), 2 mM 2-mercaptoethanol (Sigma) and 0.5 mM sodium metabisulfite. The resuspended embryos were transferred 1 ml at a time into a Wheaton homogenizer and were lysed using ten strokes of loose pestle A and ten strokes of tight pestle B. The homogenate was then centrifuged at 34,859g for 30 min using SW 40 Ti rotor and Optima L-XP series preparative ultra centrifuge (Beckman) to pellet the nuclei and debris. Supernatant was carefully collected and again centrifuged at 100,000g for 4 h to further clarify the extract. Supernatant (cytoplasmic fraction) was collected and stored at −80 °C until further use.
Biochemical purification and identification of cytoplasmic Piwi interacting peptides. All chromatographic steps were performed using ÄKTA purifier (GE Healthcare) at 4 °C. After each step, Piwi was detected by protein blotting. Cytoplasmic extract was diluted with buffer H(0) to bring down the final salt concentration of NaCl to 100 mM. The extract was then fractionated on a DEAE Sepharose (GE Healthcare) column over a linear gradient of 100-1,000 mM NaCl. Piwi was detected in the flow through of the column, showing that Piwi does not bind to this resin. Flow through was fractionated on a 10 ml Bio-Rex70 (Bio-Rad) column over a linear gradient of 100-1,000 mM NaCl. Fractions containing Piwi were again pooled; the final concentration was brought down to 100 mM and fractionated on HiPrep 16/10 Heparin FF column (GE Healthcare) over a linear gradient of 100-1,000 mM NaCl, and 7 ml fractions were collected. Fractions containing Piwi were pooled and concentrated by fractionation on a 1 ml HiTrap Heparin FF column. Three 1 ml fractions containing Piwi were pooled, and 500 µl aliquots were fractionated using Superdex 200 size exclusion chromatography. Fraction number 27 was first resolved using 4-20% gradient PAGE and stained with Coomassie blue staining. Bands detected were excised and then identified by mass spectrometry. In addition, the liquid sample was also analyzed in order to identify peptides that were missed by Coomassie blue staining. Mass spectrometry analysis was performed using services provided by ProtTech, Inc located in Norristown, PA, USA.
Whole ovary lysate preparation. Flies, either wildtype or with desired genotypes as shown in individual figures, were yeast fed for 36 h before ovary dissections. Ovaries were first dissected into ice cold phosphate buffered saline (PBS) and transferred into Eppendorf tubes. PBS was exchanged with ovary lysis buffer (20 mM HEPES, pH 7.5, 100 mM KCl, 5 mM MgCl 2 , 0.1% SDS, 0.1% sodium deoxycholate, 1% Triton X-100, 1 mM dithiothreitol and 5% glycerol) containing one tablet of complete mini EDTA-free protease inhibitor cocktail (Roche) per 10 ml of lysate and 1 mM PMSF. Lysis was performed manually using pestles designed for Eppendorf tubes. Lysate was then cleared by spinning at 16,000g for 30 min. Cleared lysate was carefully separated from the pellet and floating fat and was stored at −80 °C until use.
In vitro reconstitution of Piwi, Hop and Hsp90 complex. N-terminal His-SUMO-tagged Piwi was generated by cloning Piwi CDS into pETSUMO vector (Invitrogen). N-terminal Myc-and HA-tagged versions of Hop and Hsp90 CDS, respectively, were generated by PCR and cloned into pCR2.1 (Invitrogen) vector to create pHop and pHsp90 plasmids. Equimolar concentrations of pETSUMO-Piwi, pHop and pHsp90 were added to TnT T7-coupled rabbit reticulocyte lysate system (Promega) and were co-expressed following the manufacturer's protocol. Prior to Myc immunoprecipitation, co-expression lysate was diluted to 500 µl with H(0.1) buffer. Myc-Hop was first immunoprecipitated using 50 µl EZview Red Anti-cMyc Affinity gel (Sigma) suspension. After 3 h incubation at 4 °C, beads were washed three times with 750 µl of H(0.1) buffer. Myc-Hop was then eluted using 100 µl of 100 µg/ml c-Myc peptide (Sigma). The eluted sample was then diluted to 500 µl using H(0.1) buffer and used as input for HA tag immunoprecipitation using EZ view Red Anti-HA affinity gel (Sigma). This immunoprecipitation procedure was the same as that for Myc immunoprecipitation. After the final wash, beads were resuspended in 50 µl ×2 SDS sample loading buffer (62.5 mM Tris HCl pH 6.8, 25% glycerol, 2% SDS, 5% β-mercaptoethanol and 0.01% bromophenol blue) and we then proceeded with standard protein blotting protocol.
Immunoprecipitation and protein blotting. For Figures 2d,e , cytoplasmic extracts from 0-12 h embryos were prepared in buffer H (0.1) as described in the extract preparation section. A total of 1 mg of total protein in a volume of 1 ml was used for each immunoprecipitation reaction. The lysates were pre-cleared using Protein A/G PLUS-Agarose (Santa Cruz) for 1h at 4 °C. Precleared lysates were incubated with the appropriate antibody overnight at 4 °C with gentle agitation. 20 µl of beads were then added to the lysate-antibody mixture and incubated further for 3 h at 4 °C. Beads were then washed three times with 1 ml of H(0.1) buffer and finally analyzed by protein blotting.
For immunoprecipitation using phospho-antibodies, 15 pairs of ovaries for each genotype were lysed in 50 µl ovary lysis buffer. SDS was then added to a final concentration of 1% and the lysate was then boiled at 95 °C for 10 min to disrupt protein-protein interactions and also to inactivate any phosphotases. The lysate was then centrifuged at 16,000g for 5 min, and the supernatant was diluted ×10 with H(0.1) buffer before immunoprecipitation.
For calf intestinal phosphatase (CIP) treatment, NEB buffer 3 (NEB) was added to the ovary lysate to ×1 final concentration. CIP (NEB) was then added to a final concentration of 1 unit/µg of protein and incubated at 37 °C for 60 min before immunoprecipitation. Two-dimensional gel electrophoresis. Two-dimensional gel electrophoresis was performed following manufacturer's protocol provided for the ReadyPrep 2-D Starter kit (Bio-Rad). For each experiment, 150 µg of total ovary lysate was used. The samples were concentrated either by freeze drying or TCA precipitation and resuspended in 125 µl of two-dimension rehydration buffer. The samples were then applied to pH 3-10 IPG strips provided in the kit (BioRad). After an overnight rehydration step, the strips were electrofocused using PROTEAN IEF Cell (BioRad). Following electrofocusing, second-dimension gel electrophoresis was performed and Piwi was detected by protein blotting.
Antibodies. Anti Piwi, Aub and Ago3 antibodies, all mouse monoclonal, were a kind gift from H. Siomi and were used at a concentration of 1:10, 1:5,000 and
